TG Therapeutics, Inc. (TGTX)

Chimerix Revenue

TG Therapeutics had revenue of $120.86M in the quarter ending March 31, 2025, with 90.40% growth. This brings the company's revenue in the last twelve months to $386.39M, up 33.54% year-over-year. In the year 2024, TG Therapeutics had annual revenue of $329.00M with 40.80% growth.

• Revenue (ttm): $386.39M
• Revenue Growth: +33.54%
• P/S Ratio: 13.18
• Revenue / Employee: $1,143,154
• Employees: 338
• Market Cap: 5.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	329.00M	95.34M	40.80%
Dec 31, 2023	233.66M	230.88M	8,290.02%
Dec 31, 2022	2.79M	-3.90M	-58.36%
Dec 31, 2021	6.69M	6.54M	4,300.66%
Dec 31, 2020	152.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.